In March, their primary partner, Aequita Pharmacy, received a limited stop-service order from the Washington State Department of Health, forcing Mochi to scramble to switch thousands of patients to new pharmacies like Empower and Red Rock
While improving central energy regulation and playing a rapid antidepressant-like effect, LAC corrected systemic hyperinsulinemia and hyperglycemia in responder Flinders Sensitive Line (rFSL)
The Regulatory Truth About Melanotan-2 News 2026 Here's the honest answer: Melanotan-2 will never be FDA-approved
Identification and characterization of AES-135, a hydroxamic acid-based HDAC inhibitor that prolongs survival in an orthotopic mouse model of pancreatic cancer
The company reported what seemed like an impressive 73% year over year increase in revenue, but that still fell short of Wall Street estimatesand the regulatory pressure being applied to its hit knockoff weight-loss drug means revenue may take a bigger hit ahead
Minerva Ginecology